Cargando…
Advanced Glycation End Products, Diabetes, and Bone Strength
Diabetic patients have a higher fracture risk than expected by their bone mineral density (BMD). Poor bone quality is the most suitable and explainable cause for the elevated fracture risk in this population. Advanced glycation end products (AGEs), which are diverse compounds generated via a non-enz...
Autores principales: | Yamamoto, Masahiro, Sugimoto, Toshitsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104767/ https://www.ncbi.nlm.nih.gov/pubmed/27704396 http://dx.doi.org/10.1007/s11914-016-0332-1 |
Ejemplares similares
-
Glycemic Control and Bone in Diabetes
por: Weber, David R., et al.
Publicado: (2022) -
MicroRNA and Diabetic Bone Disease
por: Daamouch, Souad, et al.
Publicado: (2022) -
Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes
por: Beeve, Alec T., et al.
Publicado: (2019) -
Type 2 Diabetes Mellitus and Vertebral Fracture Risk
por: Koromani, Fjorda, et al.
Publicado: (2021) -
Weight Loss Interventions and Skeletal Health in Persons with Diabetes
por: Zhao, Qi, et al.
Publicado: (2022)